Concepedia

Y. Vinnyk

YV

Statistics

Publications

3

Citations

83

H-Index

3

Active since

2013

Affiliations

Kharkiv Regional Clinical Psychiatric Hospital No 3(Current)

Samsung Medical Center

Y. Vinnyk is an author at Kharkiv Regional Clinical Psychiatric Hospital No 3 specializing in pharmacology, oncology, and medicine.

Publications per year

2013–2015

3

Publications

3

Continuation of afatinib beyond progression: Results of a randomized, open-label, phase III trial of afatanib plus paclitaxel (P) versus investigator’s choice chemotherapy (CT) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) progressed on erlotinib/gefitinib (E/G) and afatanib—LUX-Lung 5 (LL5).

Martin Schüler, Keunchil Park, Jaafar Bennouna et al. · Journal of Clinical Oncology · 2014 · 34 citations

Medicine, Oncology, Pharmacology +14

Double-blind, randomized, parallel group, phase III study to demonstrate equivalent efficacy and comparable safety of CT-P6 and trastuzumab, both in combination with paclitaxel, in patients with metastatic breast cancer (MBC) as first-line treatment.

Young‐Hyuck Im, Petro Odarchenko, Daniela Grecea et al. · Journal of Clinical Oncology · 2013 · 33 citations

Medicine, Oncology, Pharmacology +17

Efficacy and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin: Results of international multicenter randomized double blind phase III study in patients with advanced non-squamous NSCLC.

O. V. Filon, Sergey Orlov, Olga Burdaeva et al. · Journal of Clinical Oncology · 2015 · 16 citations

Medicine, Oncology, Pharmacology +10

1–3 of 3